Mimotope peptide modified pompon mum-like magnetic microparticles for precise recognition, capture and biotransformation analysis of rituximab in biological fluids.
Biotransformation
Mimotope peptide
Patient serum
Peptide-based biomaterials
Precise recognition
Therapeutic monoclonal antibody
Journal
Acta pharmaceutica Sinica. B
ISSN: 2211-3835
Titre abrégé: Acta Pharm Sin B
Pays: Netherlands
ID NLM: 101600560
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
received:
20
07
2023
revised:
25
09
2023
accepted:
17
10
2023
medline:
15
3
2024
pubmed:
15
3
2024
entrez:
15
3
2024
Statut:
ppublish
Résumé
Due to low immobilized ligand density, limited binding capacity, and severe interference from serum proteins, developing ideal peptide-based biomaterials for precise recognition and
Identifiants
pubmed: 38487009
doi: 10.1016/j.apsb.2023.10.018
pii: S2211-3835(23)00412-4
pmc: PMC10935506
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1317-1328Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.